Exploring the Specificity of the PI3K Family Inhibitor LY294002

Overview

Journal Biochem J

Specialty Biochemistry

Date 2007 Feb 17

PMID 17302559

Citations 192

Authors

Severine I Gharbi

Marketa J Zvelebil

Stephen J Shuttleworth

Tim Hancox

Nahid Saghir

John F Timms

Michael D Waterfield

Affiliations

Soon will be listed here.

Abstract

The PI3Ks (phosphatidylinositol 3-kinases) regulate cellular signalling networks that are involved in processes linked to the survival, growth, proliferation, metabolism and specialized differentiated functions of cells. The subversion of this network is common in cancer and has also been linked to disorders of inflammation. The elucidation of the physiological function of PI3K has come from pharmacological studies, which use the enzyme inhibitors Wortmannin and LY294002, and from PI3K genetic knockout models of the effects of loss of PI3K function. Several reports have shown that LY294002 is not exclusively selective for the PI3Ks, and could in fact act on other lipid kinases and additional apparently unrelated proteins. Since this inhibitor still remains a drug of choice in numerous PI3K studies (over 500 in the last year), it is important to establish the precise specificity of this compound. We report here the use of a chemical proteomic strategy in which an analogue of LY294002, PI828, was immobilized onto epoxy-activated Sepharose beads. This affinity material was then used as a bait to fish-out potential protein targets from cellular extracts. Proteins with high affinity for immobilized PI828 were separated by one-dimensional gel electrophoresis and identified by liquid chromatography-tandem MS. The present study reveals that LY294002 not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family.

Citing Articles

Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model.

Han H, Efem R, Rosati B, Lu K, Maimouni S, Jiang Y Elife. 2025; 13.

PMID: 40067762 PMC: 11896608. DOI: 10.7554/eLife.96925.

LRRC8A-containing anion channels promote glioblastoma proliferation via a WNK1/mTORC2-dependent mechanism.

Fidaleo A, Bach M, Orbeta S, Abdullaev I, Martino N, Adam A bioRxiv. 2025; .

PMID: 39975357 PMC: 11838495. DOI: 10.1101/2025.02.02.636139.

Transendothelial migration of the Lyme disease spirochete involves spirochete internalization as an intermediate step through a transcellular pathway that involves Cdc42 and Rac1.

Alvarez-Olmedo D, Kamaliddin C, Verhey T, Ho M, De Vinney R, Chaconas G Microbiol Spectr. 2024; 13(2):e0222124.

PMID: 39727396 PMC: 11792520. DOI: 10.1128/spectrum.02221-24.

The Importance of Phosphoinositide 3-Kinase in Neuroinflammation.

Wright B, King S, Suphioglu C Int J Mol Sci. 2024; 25(21).

PMID: 39519189 PMC: 11546674. DOI: 10.3390/ijms252111638.

Effects of Target of Rapamycin and Phosphatidylinositol 3-Kinase Inhibitors and Other Autophagy-Related Supplements on Life Span in Male .

Bearden A, Stewart E, Casher C, Shaddix M, Nobles A, Mockett R Int J Mol Sci. 2024; 25(21).

PMID: 39519056 PMC: 11547029. DOI: 10.3390/ijms252111504.

References

Doble B, Woodgett J . GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003; 116(Pt 7):1175-86. PMC: 3006448. DOI: 10.1242/jcs.00384. View

Hennessy B, Smith D, Ram P, Lu Y, Mills G . Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005; 4(12):988-1004. DOI: 10.1038/nrd1902. View

Ye Y, Meyer H, Rapoport T . Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol. 2003; 162(1):71-84. PMC: 2172719. DOI: 10.1083/jcb.200302169. View

Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K . The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A. 2003; 100(15):8758-63. PMC: 166386. DOI: 10.1073/pnas.1433065100. View

Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, Gutbrod H . An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A. 2003; 100(26):15434-9. PMC: 307585. DOI: 10.1073/pnas.2535024100. View

Choi E, Park H, Ma J, Lee H, Kang H, Kim B . LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism. FEBS Lett. 2004; 559(1-3):141-4. DOI: 10.1016/S0014-5793(04)00058-4. View

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S . High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004; 304(5670):554. DOI: 10.1126/science.1096502. View

Abbott B, Thompson P . PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues. Bioorg Med Chem Lett. 2004; 14(11):2847-51. DOI: 10.1016/j.bmcl.2004.03.043. View

Kang J, Hong M, Kim D, Park J, Kang T, Won M . Genomic organization, tissue distribution and deletion mutation of human pyridoxine 5'-phosphate oxidase. Eur J Biochem. 2004; 271(12):2452-61. DOI: 10.1111/j.1432-1033.2004.04175.x. View

10.

Farina A, Hattori M, Qin J, Nakatani Y, Minato N, Ozato K . Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization. Mol Cell Biol. 2004; 24(20):9059-69. PMC: 517877. DOI: 10.1128/MCB.24.20.9059-9069.2004. View

11.

Tolloczko B, Turkewitsch P, Al-Chalabi M, Martin J . LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition. J Pharmacol Exp Ther. 2004; 311(2):787-93. DOI: 10.1124/jpet.104.069013. View

12.

Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y . Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem. 1993; 268(34):25846-56. View

13.

Arcaro A, Wymann M . Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J. 1993; 296 ( Pt 2):297-301. PMC: 1137693. DOI: 10.1042/bj2960297. View

14.

Vlahos C, Matter W, Hui K, Brown R . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994; 269(7):5241-8. View

15.

Ding J, Vlahos C, Liu R, Brown R, Badwey J . Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J Biol Chem. 1995; 270(19):11684-91. DOI: 10.1074/jbc.270.19.11684. View

16.

Cross D, Alessi D, Cohen P, Andjelkovich M, Hemmings B . Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995; 378(6559):785-9. DOI: 10.1038/378785a0. View

17.

Downing G, Kim S, Nakanishi S, Catt K, Balla T . Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases. Biochemistry. 1996; 35(11):3587-94. DOI: 10.1021/bi9517493. View

18.

Carpenter C, Cantley L . Phosphoinositide kinases. Curr Opin Cell Biol. 1996; 8(2):153-8. DOI: 10.1016/s0955-0674(96)80060-3. View

19.

Brunn G, Williams J, Sabers C, Wiederrecht G, Lawrence Jr J, Abraham R . Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996; 15(19):5256-67. PMC: 452270. View

20.

Meyers R, Cantley L . Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase. J Biol Chem. 1997; 272(7):4384-90. DOI: 10.1074/jbc.272.7.4384. View